Financial statements Przedsiębiorstwo Farmaceutyczne Jelfa
Cash flow statement of Przedsiębiorstwo Farmaceutyczne Jelfa
Company age:
Age:
23 y. 9 m. 14 d.
Share capital:
Share capital:
27 200 000 PLN
Cash inflows of PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | 21 213 468,16 | 25 674 024,84 | 2 625 756,09 | -3 177 721,97 | 3 906 083,22 |
| Net cash flow from investing activities | -6 988 287,02 | 648 199,38 | 50 347 522,53 | -69 515 590,93 | -7 499 245,76 |
| Net cash flow from financial activities | 496 152,02 | -13 453 785,01 | -15 300 696,96 | 6 085 593,42 | 6 363 797,57 |
| Total net cash flow | 14 721 333,16 | 12 868 439,21 | 37 672 581,66 | -66 607 719,48 | 2 770 635,03 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.